Clover Biopharmaceuticals Reveals Promising Phase I Data for Combination RSV Vaccines Clover Biopharmaceuticals shared encouraging Phase I trial results for their innovative combination RSV vaccines, which may significantly improve protection for older adults.

Clover Biopharmaceuticals Reveals Promising Phase I Data for Combination RSV Vaccines #China #Shanghai #RSV_Vaccine #Clover_Biopharma #PIV3_vaccine